Phreesia Expands Receivables Facility and Guarantees Obligations

Phreesia ( (PHR) ) has issued an update.

On April 30, 2026, Phreesia’s indirect subsidiaries AccessOne Funding and AccessOne MedCard amended their existing receivables purchase facility with PNC Bank, increasing the facility limit from $200 million to $300 million and extending its scheduled termination date from May 4, 2026 to April 30, 2029. The amendment also revised key definitions, covenants, eligibility and concentration limits, servicing fees and settlement mechanics, including raising the concentration cap on receivables from lower‑rated or unrated providers from 5% to 15% of aggregate securitization value, which enhances funding flexibility but modestly increases credit concentration risk for the underlying pool.

In connection with the amendment, Phreesia and AccessOne Holdings entered into an Amended and Restated Performance Guaranty with PNC that adds Phreesia as a joint and several co‑guarantor of AccessOne MedCard’s performance obligations under the transaction documents. This move effectively strengthens the credit support behind the facility, replacing the prior stand‑alone guaranty from AccessOne Holdings while preserving its continuing liability for existing guaranteed obligations and is likely to reinforce lender confidence and support Phreesia’s broader financing strategy following its November 12, 2025 acquisition of AccessOne Holdings.

The most recent analyst rating on (PHR) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Phreesia stock, see the PHR Stock Forecast page.

Spark’s Take on PHR Stock

According to Spark, TipRanks’ AI Analyst, PHR is a Neutral.

PHR scores in the mid-range primarily due to materially improved cash flow and margin performance, supported by earnings-call evidence of strong EBITDA/FCF execution. The score is held back by very weak technicals (deep downtrend across moving averages) and reduced FY27 revenue guidance/visibility, while valuation remains less compelling due to a negative P/E and no dividend support.

To see Spark’s full report on PHR stock, click here.

More about Phreesia

Phreesia, Inc., a Delaware corporation, operates in the healthcare payments and patient financial engagement space through subsidiaries such as AccessOne Funding and AccessOne MedCard. Its AccessOne platform originates and acquires patient receivables from healthcare providers, which are then sold into a structured receivables purchase facility that supports general corporate purposes and expands the company’s role in managing healthcare-related financial obligations.

Average Trading Volume: 2,131,327

Technical Sentiment Signal: Sell

Current Market Cap: $587.6M

See more insights into PHR stock on TipRanks’ Stock Analysis page.